The effect of chemotherapy on procoagulant microparticles in patients with cancer

The effect of chemotherapy on procoagulant microparticles in patients with cancer - Chemotherapy and microparticles

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33135

Enrollment

Registered

2009-06-02

Start date

2009-04-20

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer neoplasms

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Signed informed consent Aged over 18 Capable of making health related decisions Cancer patients, of certain types and treated with specific regimes of chemotherapy

Exclusion criteria

Exclusion criteria: Deep venous thrombosis Pulmonary Embolism Anticoagulant use

Design outcomes

Primary

Measure	Time frame
Levels and activity of microparticles in respond to a gift of chemotherapy	—

Secondary

Measure	Time frame
1. Difference in activity and levels of microparticles between blood withdrawal via vene puncture and venflon 2. Correlation between microparticle levels and activity and markers of coagulation activation.	—

Countries

Netherlands

Outcome results